Showing results (131-140 of 324) with videos related to
Sort By:
Pageof 33
Cancer|August 8, 2013
Clinical characteristics and outcomes with specific BRAF and NRAS mutations in patients with metastatic melanomaAmanda D Bucheit, Erica Syklawer, John A Jakob, et al.Cancer Epidemiology|October 23, 2018
Association between melanoma and renal-cell carcinoma for sequential diagnoses: A single-center retrospective studyKunhwa Kim, Tong Han Chung, Carol J Etzel, et al.Cancer Chemotherapy and Pharmacology|November 13, 2008
Phase I study of the combination of docetaxel, temozolomide and cisplatin in patients with metastatic melanomaKevin B Kim, Wen-Jen Hwu, Nicholas E Papadopoulos, et al.Clinical Sarcoma Research|June 21, 2017
Overexpressed PRAME is a potential immunotherapy target in sarcoma subtypesJason Roszik, Wei-Lien Wang, John A Livingston, et al.Journal of Immunological Methods|October 26, 2007
A novel strategy for rapid and efficient isolation of human tumor-specific CD4(+) and CD8(+) T-cell clonesSeung-Tae Lee, Shujuan Liu, Laszlo Radvanyi, et al.Vaccine|October 16, 2007
Survivin DNA vaccine generated specific antitumor effects in pancreatic carcinoma and lymphoma mouse modelsKuichun Zhu, Hong Qin, Soung-Chul Cha, et al.Journal of Immunology (Baltimore, Md. : 1950)|June 5, 2009
IFN-alpha enhances peptide vaccine-induced CD8+ T cell numbers, effector function, and antitumor activityAndrew G Sikora, Nina Jaffarzad, Yared Hailemichael, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 7, 2012
Detection and characterization of a novel subset of CD8⁺CD57⁺ T cells in metastatic melanoma with an incompletely differentiated phenotypeRichard C Wu, Shujuan Liu, Jessica A Chacon, et al.Cancer Immunology, Immunotherapy : CII|June 15, 2017
A phase II study of ipilimumab plus temozolomide in patients with metastatic melanomaSapna P Patel, Dae Won Kim, Roland L Bassett, et al.International Journal of Oncology|December 23, 2015
Molecular basis of antibody binding to mucin glycopeptides in lung cancerJin Qu, Hongtao Yu, Fenge Li, et al.Pageof 33